CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-03 | Schlanger David J Chief Executive Officer | Sale | −501 | $57.47 | $29K | 0 |
| 2021-05-03 | Schlanger David J Chief Executive Officer | Exercise or conversion · Employee Stock Option (right to buy) | −50,000 | 3,234,384 | ||
| 2021-05-03 | Anevski Peter President and COO | Gift | −84,000 | 583,079 | ||
| 2021-05-03 | Anevski Peter President and COO | Gift | +84,000 | 84,000 | ||
| 2021-05-03 | Anevski Peter President and COO | Sale | −16,908 | $55.99 | $947K | 67,092 |
| 2021-05-03 | Anevski Peter President and COO | Sale | −3,792 | $56.95 | $216K | 63,300 |
| 2021-05-03 | Anevski Peter President and COO | Sale | −300 | $57.36 | $17K | 63,000 |
| 2020-11-05 | Payson Norman Director | Sale | −4,982 | $26.93 | $134K | 424,617 |
| 2020-11-05 | Payson Norman Director | Sale | −1,018 | $27.44 | $28K | 423,599 |
| 2020-11-05 | Payson Norman Director | Sale | −4,982 | $26.93 | $134K | 424,617 |
| 2020-11-05 | Payson Norman Director | Sale | −1,018 | $27.44 | $28K | 423,599 |
| 2020-11-05 | Payson Norman Director | Sale | −3,736 | $26.93 | $101K | 589,264 |
| 2020-11-05 | Payson Norman Director | Sale | −764 | $27.44 | $21K | 588,500 |
| 2020-11-04 | Payson Norman Director | Sale | −2,036 | $26.27 | $53K | 433,563 |
| 2020-11-04 | Payson Norman Director | Sale | −3,964 | $26.94 | $107K | 429,599 |
| 2020-11-04 | Payson Norman Director | Sale | −2,036 | $26.27 | $53K | 433,563 |
| 2020-11-04 | Payson Norman Director | Sale | −3,964 | $26.94 | $107K | 429,599 |
| 2020-11-04 | Payson Norman Director | Sale | −1,528 | $26.27 | $40K | 595,972 |
| 2020-11-04 | Payson Norman Director | Sale | −2,972 | $26.94 | $80K | 593,000 |
| 2020-10-30 | Bealer Jennifer EVP, General Counsel | Exercise or conversion | +2,291 | $0.91 | $2K | 65,606 |
Page 74 of 77 · 1,524 trades